Acrivon Therapeutics ACRV
- ACR-2316 — Small Cell Lung Cancer Phase 1
- ACR-2316 — Non-Small Cell Lung Cancer Phase 1
PKMYT1 (1 companies · 2 programs)
Companies with an active program directed at PKMYT1.
Companies with an active program directed at PKMYT1.